Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Primary Results of NCCH1607/PATHWAY, an Asian International Double-Blind Randomized Phase 3 Trial - Palbociclib + Tamoxifen ± Goserelin in Women With HR+/HER2- Advanced BC"

111 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login